|
著者・共著者 |
発行年月 |
表題 |
掲載誌名 |
巻号頁 |
| 1 | Maite ALVAREZ†, Antonio PIERINI, Federico SIMONETTA, Jeanette BAKER, Kristina MAAS-BAUER, HIRAI Toshihito, Robert S. NEGRIN* | 2021/01 | Infusion of host-derived unlicensed NK cells improves donor engraftment in non-myeloablative allogeneic hematopoietic cell transplantation. | | 11:614250-614250 |
| 2 | TAKAGI Toshio†* | 2021/01 | Editorial comment to successful recovery from coronavirus disease 2019 in a living kidney transplant recipient using low-dose methylprednisolone. | | 4(1):25-25 |
| 3 | MIURA Kenichiro, SHIRAI Yoko, KANEKO Naoto, YABUUCHI Tomoo, ISHIZUKA Kiyonobu, HORITA Shigeru, FURUSAWA Miyuki, UNAGAMI Kohei, OKUMI Masayoshi, ISHIDA Hideki, TANABE Kazunari, KOIKE Junki, HONDA Kazuho, YAMAGUCHI Yutaka, HATTORI Motoshi†* | 2021/01 | Chronic active antibody-mediated rejection with linear IgG deposition on glomerular capillaries in a kidney transplant recipient. | Nephron | 144(S1):97-101 |
| 4 | Ogawa Yuko†*, Abe Koichiro, Hata Keisuke, Yamamoto Tomoko, Sakai Shuji | 2021/01 | A case of pulmonary tumor embolism diagnosed with respiratory distress immediately after FDG-PET/CT scan. | Radiol Case Rep | 16(3):718-722 |
| 5 | ISHIHARA Hiroki†, TAKAGI Toshio*, KONDO Tsunenori, FUKUDA Hironori, TACHIBANA Hidekazu, YOSHIDA Kazuhiko, IIZUKA Junpei, KOBAYASHI Hirohito, ISHIDA Hideki, TANABE Kazunari | 2021/01 | Prognostic impact of metastasectomy in renal cell carcinomain the postcytokine therapy era. | Urol Oncol | 39(1):77.e17-77.e25. |
| 6 | 山川貴史†, 石井瑠美, 神澤太一, 石郷岡秀俊, 雑賀寛, 石井保之, 田邉一成 | 2021/02 | ラパマイシンとNKT活性化剤の併用による新規移植免疫寛容マウスモデルの確立 | | 40:70-71 |
| 7 | Federico SIMONETTA†, Israt S. ALAM, Juliane K. LOHMEYER, Bita SAHAF, Zinaida GOOD, Weiyu CHEN, Zunyu XIAO, HIRAI Toshihito, Lukas SCHELLER, Pujan ENGELS, Ophir VERMESH, Elise ROBINSON, Tom HAYWOOD, Ataya SATHIRACHINDA, Jeanette BAKER, Meena B. MALIPATLOLLA, Liora M. SCHULTZ, Jay Y. SPIEGEL, Jason T. LEE, David B. MIKLOS, Crystal L. MACKALL, Sanjiv S. GAMBHIR, Robert S. NEGRIN | 2021/02 | Molecular imaging of chimeric antigen receptor T cells by ICOS-ImmunoPET. | Clin Cancer Res | 27(4):1058-1068 |
| 8 | TAKAGI Toshio†*, YOSHIDA Kazuhiko, KONDO Tsunenori, KOBAYASHI Hirohito, IIZUKA Junpei, OKUMI Masayoshi, ISHIDA Hideki, TANABE Kazunari | 2021/02 | Comparisons of surgical outcomes between transperitoneal and retroperitoneal approaches in robot‑assisted laparoscopic partial nephrectomy for lateral renal tumors: a propensity score‑matched comparative analysis. | | 15(1):99-104 |
| 9 | MIYOSHI Yasuhide†*, YASUI Masato, YONEYAMA Shuko, KAWAHARA Takashi, NAKAGAMI Yoshihiro, OHNO Yoshimasa, IIZUKA Junpei, TANABE Kazunari, HASHIMOTO Yasunobu, TSUMURA Hideyasu, TABATA Ken-ichi, IWAMURA Masatsugu, YANO Akihiro, KAWAKAMI Satoru, UEMURA Hiroji | 2021/03 | A novel prognostic model for Japanese patients with newly diagnosed bone-metastatic hormone-naïve prostate cancer. | | 2(2):105-114 |
| 10 | Anri Sawada†*, Masayoshi Okumi, Shigeru Horita, Tomomi Tamura, Sekiko Taneda, Hideki Ishida, Motoshi Hattori, Kazunari, Tanabe Kosaku, Nitta Kazuho Honda, Junki, Koike, Yoji Nagashima , Akira Shimizu | 2021/03 | Monoclonal and polyclonal immunoglobulin G deposits on tubular basement membranes of native and pretransplant kidneys: A retrospective study | Pathol Int | 71:406-414 |
| 11 | Arimura Ken†, Tagaya Etsuko, Kikuchi Ken, Mitsuda Toshihiro, Yasuda Gaku, Azuma Haruna, Konda Naoko, Ikarashi Yuichi, Chiba Yukihide, Kusama Kaoru, Sakama Reiko, Hagiwara Shotaro, Shimizu Satoru, Shimamoto Ken, Nomura Minoru, Yaguchi Arino, Niinami Hiroshi, Kondo Mitsuko, Tanabe Kazunari, Kawana Masatoshi | 2021/05 | Polymerase-chain reaction testing to prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection in Shinjuku, an epicenter in Tokyo: The Tokyo Women's Medical University model. | Respir Investig | 59(3):356-359 |
| 12 | 橋本哲也†*, 野並裕司, 金室俊子, 吉田一彦, 鬼塚裕美, 板垣裕子, 増井憲太, 山本智子, 澤田達男, 長嶋洋治 | 2021/06 | 術後に形成された空洞に再発をきたした乳頭状腎細胞癌の 1 例 | | 60(3):150-155 |
| 13 | UNAGAMI Kohei†*, ISHIDA Hideki, FURUSAWA Miyuki, KITAJIMA Kumiko, HIRAI Toshihito, KAKUTA Yoichi, TOKI Daisuke, SHIMIZU Tomokazu, OMOTO Kazuya, OKUMI Masayoshi, NITTA Kosaku, TANABE Kazunari | 2021/06 | Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7 years of follow-up after renal transplantation. | Nephrol Dial Transplant | 36(6):1120-1129 |
| 14 | SAWADA Anri†*, OKUMI Masayoshi, HORITA Shigeru, TAMURA Tomomi, TANEDA Sekiko, ISHIDA Hideki, HATTORI Motoshi, TANABE Kazunari, NITTA Kosaku, HONDA Kazuho, KOIKE Junki, NAGASHIMA Yoji, SHIMIZU Akira | 2021/06 | Monoclonal and polyclonal immunoglobulin G deposits on tubular basement membranes of native and pretransplant kidneys: A retrospective study. | Pathol Int | 71(6):406-414 |
| 15 | SAWADA Anri†*, OKUMI Masayoshi, HORITA Shigeru, TAMURA Tomomi, TANEDA Sekiko, ISHIDA Hideki, HATTORI Motoshi, TANABE Kazunari, NITTA Kosaku, HONDA Kazaho, KOIKE Junki, NAGASHIMA Yoji, SHIMIZU Akira | 2021/06 | Monoclonal and polyclonal immunoglobulin G deposits on tubular basement membranes of native and pretransplant kidneys: A retrospective study. | Pathol Int | 71(6):406-414 |
| 16 | 服部元史*, 石塚喜世伸, 金子直人, 三浦健一郎, 白井陽子, 安藤太郎, 白鳥孝俊, 薮内智朗, 石和翔, 永田智, 大川拓也†, 世川修, 末吉亮, 田邉一成, 鈴木万里, 石田英樹 | 2021/07 | 腎移植に9年後にTMAを発症した1例 | | 41:92-95 |
| 17 | 服部元史*, 石塚喜世伸, 金子直人, 三浦健一郎, 白井陽子, 安藤太郎, 白鳥孝俊, 田邉一成, 石田英樹, 薮内智朗, 石和翔, 大川拓也†, 末吉亮, 世川修, 永田智, 鈴木万里 | 2021/07 | 先行的腎移植と同時に膀胱皮膚瘻造設を行った後部尿道弁の8歳男児例 | | 41:92-95 |
| 18 | 服部元史*, 石塚喜世伸, 金子直人, 三浦健一郎, 白井陽子, 安藤太郎, 白鳥孝俊, 鈴木万里, 鈴木美穂†, 永田智, 田邉一成, 薮内智朗 | 2021/07 | 非特異的な腹部症状契機に尿路結石症と診断した1例 | | 41:89-91 |
| 19 | 石田英樹†* | 2021/07 | 東京女子医科大学における抗HLA抗体陽性患者に対する脱感作治療の実際－高用量ガンマグロブリンによる脱感作治療を中心に－ | 日臨腎移植会誌 | 9(1):9-14 |
| 20 | 石田英樹†*, 海上耕平, 神澤太一, 田邉一成, 土屋真美, 石田資子, 高柳嘉代, 三浦ひとみ | 2021/07 | 腎移植患者におけるアンチゲネミア法とPCR法の比較検討 | 日臨腎移植会誌 | 9(1):89-94 |
| 21 | MIYAIRI Satoshi, UEDA Daisuke, YAGISAWA Takafumi, OKADA Daigo, Karen S. KESLAR, TANABE KAZUNARI, Nina DVORINA, Anna VALUJSKIKH, William M. BALDWIN 3RD, Stanley L. HAZEN, Robert L.FAIRCHILD | 2021/07 | Recipient myeloperoxidase-producing cells regulate antibody-mediated acute versus chronic kidney allograft rejection. | JCI Insight | 6(13):e148747 |
| 22 | KIJIMA Yu†*, SHIMIZU Tomokazu, KATO Shinya, SEKIDO Eri, KANO Kana, TOGUCHI Makoto, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio | 2021/09 | Suspected pneumonia caused by coronavirus disease 2019 after kidney transplantation: A case report. | Transplant Proc | in press |
| 23 | Olivier Aubert†, Daniel Yoo, Dina Zielinski, Emanuele Cozzi, Massimo Cardillo, Michael Durr, Beatriz Dominguez-Gil, Elisabeth Coll, Margarida Ivo Da Silva, Ville Sallinen, Karl Lemstrom, Karsten Midtvedt, Camilo Ulloa, Franz Immer, Annemarie Weissenbacher, Natalie Vallant, Nikolina Basic-Jukic, TANABE Kazunari, Georgios Papatheodoridis, Georgia Menoudakou, Martin Torres, Carlos Soratti, Daniela Hansen Krogh, Carmen Lefaucheur, Gustavo Ferreira, Helio Tedesco Silva Jr, David Hartell, John Forsythe, Lisa Mumford, Peter P Reese, Francois Kerbaul, Christian Jacquelinet, Serge Vogelaar, Vassilios Papalois, Alexandre Loupy* | 2021/10 | COVID-19 pandemic and worldwide organ transplantation: a population-based study. | | 6(10):e709-e719 |
| 24 | KIJIMA Yu†*, SHIMIZU Tomokazu, SEKIDO Eri, KATO Shinya, KANO Kana, TOGUCHI Makoto, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio | 2021/10 | Allogeneic kidney transplantation after COVID-19: A case report. | Transplant Proc | in press |
| 25 | KIJIMA Yu†*, IIDA Shoichi, NOZAKI Taiji, SEKIDO Eri, TOGUCHI Makoto, HORIUCHI TOSHIHIDE, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, SHIMIZU Tomokazu | 2021/10 | Fluorescence in situ hybridization for the origin of de novo renal cell carcinoma in a kidney allograft: A case report. | Transplant Proc | 53(8):2552-2555 |
| 26 | KIJIMA Yu†*, SHIMIZU Tomokazu, KATO Shinya, SEKIDO Eri, KANO Kana, TOGUCHI Makoto, HORIUCHI Toshihide, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio | 2021/12 | A case of novel coronavirus disease after combination therapy with nivolumab and ipilimumab for metastatic renal cell carcinoma | | Early View |
| 27 | KIJIMA Yu†*, SHIMIZU Tomokazu, KATO Shinya, KANO Kana, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio | 2021/12 | A Case Report of COVID-19 infection after kidney transplantation treated with casirivimab-imdevimab and mycophenolate mofetil changed to everolimus. | Transplant Proc | in press |
| 28 | KIJIMA Yu†*, SHIMIZU Tomokazu, KATO Shinya, SEKIDO Eri, KANO Kana, TOGUCHI Makoto, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio | 2021/12 | Two laparotomy surgeries to achieve hemostasis after kidney transplantation in a patient with frailty: a case report | Transplant Proc | in press |
| 29 | KOBARI Yuki,YOSHIDA Kazuhiko,IIZUKA Junpei,KONDO Tsunenori,ISHIDA Hideki,TANABE Kazunari,TAKAGI Toshio | 2021/09 | Three Cases of Nivolumab Plus Ipilimumab Therapy in Haemodialysis Pateints With Metastatic Renal Cell Cacinoma | in vivo | 35:3585-3589 |
| 30 | Satoshi Miyairi, Daisuke Ueda, Takafumi Yagisawa, Daigo Okada, Karen S Keslar, Kazunari Tanabe, Nina Dvorina, Anna Valujskikh, William Baldwin Rd, Stanley L Hazen, Robert L Fairchild | 2021 | Recipient myeloperoxidase-producing cells regulate antibodymediated acute versus chronic kidney allograft rejection | | 6(13):e148747 |
| 31 | Takafumi Yagisawa, Toshio Takagi, Kazuhiko Yoshida, Keisuke Hata, Yasuto Muromiya, Tsunenori Kondo, Kazunari Tanabe | 2021 | Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma | | |
| 32 | Takagi T, Yoshida K, Kondo T, Kobayashi H, Iizuka J, Okumi M, Ishida H, Tanabe T | 2021 | Comparisons of surgical outcomes between transperitoneal and retroperitoneal approaches in robot-assisted laparoscopic partial nephrectomy for lateral renal tumors: a propensity score-matched comparative analysis | | 15(1):99-104 |
| 33 | Takagi T, Yoshida K, Kondo T, Fukuda H, Ishihara H, Kobayashi H, Iizuka J, Ishida H, Tanabe K. | 2021/09 | Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy. | | |
| 34 | Yagisawa T, Takagi T, Yoshida K, Hata K, Iizuka J, Muromiya Y, Kondo T, Tanabe K. | 2021/08 | Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma. | | |
| 35 | Minoda R, Takagi T, Yoshida K, Kondo T, Tanabe K. | 2021/12 | Comparison of surgical outcomes between enucleation and standard resection in robot-assisted partial nephrectomy for completely endophytic renal tumors through a 1:1 propensity score-matched analysis. | | 35(12):1779-1784 |
| 36 | Ishihara H, Takagi T, Yoshida K, Hashimoto Y, Kondo T, Tanabe K. | 2021/10 | Tumor response in primary kidney lesions and metastatic lesions in nivolumab plus ipilimumab therapy for advanced renal cell carcinoma without prior nephrectomy: Preliminary results of a multi-institutional study. | | 28(10):1075-1076. |
| 37 | Watanabe S, Takagi T, Yoshida K, Unagami K, Kanzawa T, Iizuka J, Ishida H, Tanabe K | 2021/05 | Robot-Assisted Laparoscopic Partial Nephrectomy for Allograft Renal Cell Carcinoma: A Case Report. | | S0041-1345(21)00231-1 |
| 38 | Toguchi M, Takagi T, Ogawa Y, Morita S, Yoshida K, Kondo T, Iizuka J, Ishida H, Nagashima Y, Tanabe K | 2021/01 | Detection of a peritumoral pseudocapsule in patients with renal cell carcinoma undergoing robot-assisted partial nephrectomy using enhanced MDCT. | | 26;11(1):2245. |
| 39 | Kobari Y, Takagi T, Yoshida K, Ishida H, Tanabe K | | Comparison of postoperative recovery after robot-assisted partial nephrectomy of T1 renal tumors through retroperitoneal or transperitoneal approach:A Japanese single institutional analysis | | 28(2)183-188 |
| 40 | Ishihara H, Takagi T, Kondo T, Fukuda H, Tachibana H, Yoshida K, Iizuka J, Kobayashi H, Ishida H, Tanabe K | 2021/02 | Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era. | Jpn J Clin Oncol. | 8;51(2):296-304. |
| 41 | Tachibana H, Kondo T, Ishiyama Y, Yoshino M, Yoshida K, Izuka J, Tanabe K, Takagi T | 2021/12 | New longitudinal component of the RENAL nephrometry score for predicting the operative complexity in transperitoneal robot-assisted partial nephrectomy. | | |
| 42 | Ishiyama Y, Kondo T, Ishihara H, Yoshida K, Iizuka J, Tanabe K, Takagi T | 2021/11 | Association between Ureteral Clamping Time and Acute Kidney Injury during Robot-Assisted Radical Cystectomy. | | 28(6):4986-4997 |
| 43 | Tachibana H, Nemoto Y, Ishihara H, Fukuda H, Yoshida K, Iizuka J, Hashimoto Y, Kondo T, Tanabe K, Takagi T | 2021/10 | Predictive Impact of Early Changes in Serum C-Reactive Protein Levels in Nivolumab Plus Ipilimumab Therapy for Metastatic Renal Cell Carcinoma. | | S1558-7673(21)00196-8. |
| 44 | Nemoto Y, Ishihara H, Nakamura K, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Kondo T, Takagi T | 2021/10 | Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma. | | |
| 45 | Kobari Y, Yoshida K, Iizuka J, Kondo T, Ishida H, Tanabe K, Takagi T. | 2021/11 | Three Cases of Nivolumab Plus Ipilimumab Therapy in Haemodialysis Patients With Metastatic Renal Cell Carcinoma. | | 35(6):3585-3589. |
| 46 | Ishihara H, Kondo T, Nakamura K, Nemoto Y, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Takagi T | 2021/09 | JAssociation of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma. | | |
| 47 | Ishihara H, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Takagi T, Iizuka J, Ishida H, Kondo T, Tanabe K | 2021/08 | Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell Carcinoma | | |
| 48 | Ishiyama Y, Kondo T, Tachibana H, Yoshida K, Takagi T, Iizuka J, Tanabe K. | 2021/09 | Limited impact of warm ischemic threshold for partial nephrectomy in the robotic surgery era: A propensity score matching study. | | |
| 49 | Yoshino M, Ishihara H, Ishiyama Y, Tachibana H, Toki D, Yamashita K, Kobayashi H, Fukuda H, Yoshida K, Takagi T, Iizuka J, Ishida H, Kondo T, Tanabe K. | 2021/09 | Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell Carcinoma | | 35(5):2855-2862 |
| 50 | Ishiyama Y, Kondo T, Nemoto Y, Kobari Y, Ishihara H, Tachibana H, Yoshida K, Hashimoto Y, Takagi T, Iizuka J, Tanabe K. | 2021/07 | Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma | | S1078-1439(21)00252-0 |
| 51 | Ishihara H, Nemoto Y, Nakamura K, Ikeda T, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Takagi T, Ishida H, Kondo T, Tanabe K. | 2021/07 | Prognostic Impact of Early Treatment Interruption of Nivolumab Plus Ipilimumab Due to Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Multi-Institution Retrospective Study. | | 16(4):493-502. |
| 52 | Ikeda T, Ishihara H, Nemoto Y, Tachibana H, Fukuda H, Yoshida K, Takagi T, Iizuka J, Hashimoto Y, Ishida H, Kondo T, Tanabe K | 2021/10 | Prognostic impact of immune-related adverse events in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab | | 39(10):735.e9-735.e16 |
| 53 | Ishiyama Y, Kondo T, Yoshida K, Takagi T, Iizuka J, Tanabe K. | 2021/10 | Surgery for renal cell carcinoma extending to the right atrium in Japanese institutions: Focusing on cardiopulmonary bypass with or without deep hypothermic circulatory arrest | | 28(10):1001-1007. |
| 54 | Kondo T, Sassa N, Yamada H, Takagi T, Iizuka J, Kobayashi H, Yoshida K, Fukuda H, Ishihara H, Tanabe K, Tsuzuki T. | 2021/10 | Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study. | | 53(6):720-727 |
| 55 | Ishiyama Y, Kondo T, Tachibana H, Yoshida K, Takagi T, Iizuka J, Tanabe K. | 2021/10 | Greater Renal Function Benefit from Enucleation Technique for More Complex Renal Tumors in Robot-Assisted Partial Nephrectomy. | | 35(10):1512-1519 |
| 56 | Ishiyama Y, Kondo T, Nemoto Y, Kobari Y, Ishihara H, Tachibana H, Yoshida K, Hashimoto Y, Takagi T, Iizuka J, Tanabe K. | 2021/03 | Predictive Impact of Prognostic Nutritional Index on Pembrolizumab for Metastatic Urothelial Carcinoma Resistant to Platinum-based Chemotherapy | | 41(3):1607-1614 |
| 57 | Ishihara H, Fukuda H, Tachibana H, Yoshida K, Kobayashi H, Takagi T, Iizuka J, Ishida H, Nagashima Y, Kondo T, Tanabe K | 2021/06 | Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma | | 25(6):674-682. |
| 58 | Nemoto Y, Kondo T, Ishihara H, Takagi T, Fukuda H, Yoshida K, Iizuka J, Ishida H, Tanabe K. | 2021/03 | The Controlling Nutritional Status CONUT Score in Patients With Advanced Bladder Cancer After Radical Cystectomy | | 35(2):999-1006. |
| 59 | Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; | 2021/04 | CLEAR Trial Investigators Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma | | 384(14):1289-1300. |
| 60 | Ishihara H, Tachibana H, Takagi T, Yoshida K, Kondo T, Tanabe K | 2021/05 | Effect of improved systemic therapy on patient survival in metastatic non-clear-cell renal cell carcinoma | | 28(5):605-607. |
| 61 | Ogawa Y, Morita S, Takagi T, Yoshida K, Tanabe K, Nagashima Y, Nishina Y, Sakai S | 2021/09 | Early dark cortical band sign on CT for differentiating clear cell renal cell carcinoma from fat poor angiomyolipoma and detecting peritumoral pseudocapsule. | | |
| 62 | Watanabe S, Ishihara H, Takagi T, Kondo T, Ishiyama R, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Ishida H, Tanabe K. | 2021/04 | Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus. | | 51(5):819-825. |
| 63 | Ishiyama Y, Kondo T, Kubota S, Shimada K, Yoshida K, Takagi T, Iizuka J, Tanabe K | 2021/04 | Therapeutic benefit of lymphadenectomy for older patients with urothelial carcinoma of the upper urinary tract: a propensity score matching study. | | 51(5):802-809 |
| 64 | Ishihara H, Takagi T, Kondo T, Fukuda H, Tachibana H, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H, Tanabe K | 2021/04 | Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data | | 51(5):793-801. |
| 65 | Tachibana H, Kondo T, Ishihara H, Fukuda H, Yoshida K, Takagi T, Izuka J, Kobayashi H, Tanabe K | 2021/04 | Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma | | 51(4):646-653 |
| 66 | Ishihara H, Fukuda H, Takagi T, Kondo T, Tachibana H, Yoshida K, Iizuka J, Kobayashi H, Ishida H, Tanabe K | 2021/01 | Efficacy of nivolumab versus molecular-targeted therapy as second-line therapy for metastatic renal cell carcinoma:Real-world data from two Japanese institutions | | 28(1):99-106 |
| 67 | Ishiyama Y, Kondo T, Tachibana H, Ishihara H, Fukuda H, Yoshida K, Takagi T, Iizuka J, Tanabe K. | 2021/05 | Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma | | 26(3):552-561. |
| 68 | Hiroki Ishihara 1, Toshio Takagi 2, Tsunenori Kondo 3, Hironori Fukuda 1, Hidekazu Tachibana 3, Kazuhiko Yoshida 1, Junpei Iizuka 1, Hirohito Kobayashi 3, Hideki Ishida 1, Kazunari Tanabe 1 | 2021/01 | Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era | | |
| 69 | Ishihara H, Takagi T, Kondo T, Fukuda H, Tachibana H, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H, Tanabe K | 2021/02 | Prognostic impact of systemic therapy change in metastatic renal cell carcinoma treated with cytoreductive nephrectomy. | | 51(2):296-304. |
| 70 | Shun Watanabe, Hiroki Ishihara (corresponding author), Toshio Takagi , Tsunenori Kondo, Ryo Ishiyama, Hironori Fukuda , Kazuhiko Yoshida, Junpei Iizuka, Hirohito Kobayashi, Hideki Ishida, Kazunari Tanabe | 2021/04 | Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus | | |
| 71 | 巴ひかる† | | 難治性過活動膀胱に対する専門的診療について | | |
| 72 | 巴ひかる、関口由紀、尾崎由美、二宮典子、佐藤嘉一、高橋悟 | | 外陰膣症状質問票（Vulvovaginal Symptoms Questionnaire:VSQ）の日本語版作成と言語学的妥当性の検討 | | |
| 73 | 近藤恒徳† | | 高齢者、CKD患者における外科的治療と周術期化学療法の適応の考え方 | | 34(6) 557-565 |
| 74 | 巴ひかる† | | 低活動膀胱/排尿筋低活動を伴う腹圧性尿失禁：尿失禁手術は選択肢になるのか？ | | |
| 75 | Kondo T, Sassa N, Yamada H, Takagi T, Iizuka J, Kobayashi H, Yoshida K, Fukuda H, Ishihara H, Tanabe K, Tsuzuki T | | Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study | | 53(6):720-727. |
| 76 | Ishihara H, Takagi T, Yoshida K, Hashimoto Y, Kondo T, Tanabe K | | Tumor response in primary kidney lesions and metastatic lesions in nivolumab plus ipilimumab therapy for advanced renal cell carcinoma without prior nephrectomy: Preliminary results of a multi-institutional study. | | 28(10):1075-1076 |
| 77 | Takashi Ikeda , Hiroki Ishihara (corresponding author) , Yuki Nemoto , Hidekazu Tachibana , Hironori Fukuda , Kazuhiko Yoshida , Toshio Takagi , Junpei Iizuka, Yasunobu Hashimoto, Hideki Ishida, Tsunenori Kondo , Kazunari Tanabe | | Prognostic impact of immune-related adverse events in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab | | |
| 78 | 巴ひかる† | | Female urology:過去から未来へ | | |
| 79 | 巴ひかる | | 特集 女性骨盤底医学の最前線 治療 腹腔鏡下仙骨膣固定術 LSCとRSCの比較 | | |
| 80 | 巴ひかる | | office Urologistsへのアンケート「女性骨盤底の診療の実際」 | | |
| 81 | 巴ひかる | | 特集 女性骨盤底医学の最前線 特集に寄せて | | |
| 82 | Kondo T | | Editorial Comment to Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018 | | 28(12):1272-1273 |
| 83 | "Ishiyama Y, Kondo T, Kubota S, Shimada K, Yoshida K, Takagi T, Iizuka J,
Tanabe K." | | Therapeutic benefit of lymphadenectomy for older patients with
urothelial carcinoma of the upper urinary tract: a propensity score matching study | | |
| 84 | Ishiyama Y, Kondo T, Tachibana H, Yoshida K, Takagi T, Iizuka J, Tanabe K. | | Limited impact of warm ischemic threshold for partial nephrectomy in the robotic surgery era: A propensity score matching study | | |
| 85 | Ishiyama Y, Kondo T, Nemoto Y, Kobari Y, Ishihara H, Tachibana H, Yoshida K,Hashimoto Y, Takagi T, Iizuka J, Tanabe K. | | Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma | | |
| 86 | Ishiyama Y, Kondo T, Nemoto Y, Kobari Y, Ishihara H, Tachibana H, Yoshida K, Hashimoto Y, Takagi T, Iizuka J, Tanabe K. Predictive Impact of | | Prognostic Nutritional Index on Pembrolizumab for Metastatic Urothelial Carcinoma Resistant to Platinum-based Chemotherapy | | |
| 87 | Ishiyama Y, Kondo T, Tachibana H, Ishihara H, Fukuda H, Yoshida K, Takagi T, Iizuka J, Tanabe K. | | Predictive role of γ-glutamyltransferase in patients
receiving nivolumab therapy for metastatic renal cell carcinoma | | |
| 88 | Ishiyama Y, Kondo T, Ishihara H, Yoshida K, Iizuka J, Tanabe K, Takagi T. | | Association between Ureteral Clamping Time and Acute Kidney Injury during Robot-Assisted Radical Cystectomy | | |
| 89 | Ishiyama Y, Kondo T, Yoshida K, Takagi T, Iizuka J, Tanabe K. | | Surgery for renal cell carcinoma extending to the right atrium in Japanese institutions: Focusing on cardiopulmonary bypass with or without deep hypothermic circulatory arrest | | |
| 90 | Ishiyama Y, Kondo T, Tachibana H, Yoshida K, Takagi T, Iizuka J, Tanabe K. | | Greater Renal Function Benefit from Enucleation Technique for More Complex Renal Tumors in Robot-Assisted Partial Nephrectomy | | |
| 91 | Tachibana H, Kondo T, Ishiyama Y, Yoshino M, Yoshida K, Izuka J, Tanabe K, Takagi T | | New longitudinal component of the RENAL nephrometry score for predicting the operative complexity in transperitoneal robot-assisted partial nephrectomy. | | Epub ahead of pring |
| 92 | Ishihara H, Kondo T, Nakamura K, Nemoto Y, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Takagi T | | Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma. | | 51(12):1751-1756 |
| 93 | Takagi T, Yoshida K, Kondo T, Fukuda H, Ishihara H, Kobayashi H, Iizuka J, Ishida H, Tanabe K | | Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy. | | 51(12):1744-1750 |
| 94 | Ishiyama Y, Kondo T, Tachibana H, Yoshida K, Takagi T, Iizuka J, Tanabe K | | Limited impact of warm ischemic threshold for partial nephrectomy in the robotic surgery era: A propensity score matching study. | | 28(12):1219-1225 |
| 95 | Ishiyama Y, Kondo T, Nemoto Y, Kobari Y, Ishihara H, Tachibana H, Yoshida K, Hashimoto Y, Takagi T, Iizuka J, Tanabe K | | Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma. | | 39(12):834.e21-834.e28. |
| 96 | Minoda R, Takagi T, Yoshida K, Kondo T, Tanabe K | | Comparison of Surgical Outcomes Between Enucleation and Standard Resection in Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Tumors Through a 1:1 Propensity Score-Matched Analysis. | | 35(12):1779-1784 |
| 97 | Ishiyama Y, Kondo T, Ishihara H, Yoshida K, Iizuka J, Tanabe K, Takagi T | | Association between Ureteral Clamping Time and Acute Kidney Injury during Robot-Assisted Radical Cystectomy. | | 28(6):4986-4997. |
| 98 | Tachibana H, Omae K, Ishihara H, Fukuda H, Yoshida K, Iizuka J, Tanabe K, Kondo T, Takagi T | | Validation of predictive model for new baseline renal function after robot-assisted partial nephrectomy or radical nephrectomy in Japanese patients. | | Epub ahead of pring |
| 99 | Kobari Y, Yoshida K, Iizuka J, Kondo T, Ishida H, Tanabe K, Takagi T | | Three Cases of Nivolumab Plus Ipilimumab Therapy in Haemodialysis Patients With Metastatic Renal Cell Carcinoma. | | 35(6):3585-3589 |
| 100 | Tachibana H, Nemoto Y, Ishihara H, Fukuda H, Yoshida K, Iizuka J, Hashimoto Y, Kondo T, Tanabe K, Takagi | | Predictive Impact of Early Changes in Serum C-Reactive Protein Levels in Nivolumab Plus Ipilimumab Therapy for Metastatic Renal Cell Carcinoma. | | 13:S1558- 7673(21)00196-8 |
| 101 | Ishiyama Y, Kondo T, Yoshida K, Takagi T, Iizuka J, Tanabe K | | Surgery for renal cell carcinoma extending to the right atrium in Japanese institutions: Focusing on cardiopulmonary bypass with or without deep hypothermic circulatory arrest. | | 28(10):1001-1007 |
| 102 | Ishiyama Y, Kondo T, Tachibana H, Yoshida K, Takagi T, Iizuka J, Tanabe K | | Greater Renal Function Benefit from Enucleation Technique for More Complex Renal Tumors in Robot-Assisted Partial Nephrectomy. | | 35(10):1512-1519. |
| 103 | Yoshino M, Ishihara H, Ishiyama Y, Tachibana H, Toki D, Yamashita K, Kobayashi H, Fukuda H, Yoshida K, Takagi T, Iizuka J, Ishida H, Kondo T, Tanabe K | | Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell Carcinoma. | | 35(5):2855-2862 |
| 104 | Ishihara H, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Takagi T, Iizuka J, Ishida H, Kondo T, Tanabe K | | Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell Carcinoma. | | 26:1-8. |
| 105 | Yagisawa T, Takagi T, Yoshida K, Hata K, Iizuka J, Muromiya Y, Kondo T, Tanabe K | | Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma. | | Online ahead of print |
| 106 | Ishihara H, Nemoto Y, Nakamura K, Ikeda T, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Takagi T, Ishida H, Kondo T, Tanabe K | | Prognostic Impact of Early Treatment Interruption of Nivolumab Plus Ipilimumab Due to Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Multi-Institution Retrospective Study. | | Jul;16(4):493-502 |
| 107 | Ishihara H, Fukuda H, Tachibana H, Yoshida K, Kobayashi H, Takagi T, Iizuka J, Ishida H, Nagashima Y, Kondo T, Tanabe K. | | Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma. | | 25(6):674-682. |
| 108 | Ishihara H, Tachibana H, Takagi T, Yoshida K, Kondo T, Tanabe K | | Effect of improved systemic therapy on patient survival in metastatic non-clear-cell renal cell carcinoma. | | 28(5):605-607. |
| 109 | Watanabe S, Ishihara H, Takagi T, Kondo T, Ishiyama R, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Ishida H, Tanabe K | | Therapeutic benefit of lymphadenectomy for older patients with urothelial carcinoma of the upper urinary tract: a propensity score matching study. | | 51(5):802-809 |
| 110 | Ishihara H, Takagi T, Kondo T, Fukuda H, Tachibana H, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H, Tanabe K | | Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data. | | 51(5):793-801 |
| 111 | Hinata N, Shiroki R, Tanabe K, Eto M, Takenaka A, Kawakita M, Hara I, Hongo F, Ibuki N, Nasu Y, Teishima J, Kawai N, Kawauchi A, Kondo T, Kawamorita N, Oyama C, Horie S, Shimbo M, Kato M, Kanayama H, Koito Y, Fujisawa M; Japanese Society of Endourology. | | Robot-assisted partial nephrectomy versus standard laparoscopic partial nephrectomy for renal hilar tumor: A prospective multi-institutional study. | | 28(4):382-389 |
| 112 | Tachibana H, Kondo T, Ishihara H, Fukuda H, Yoshida K, Takagi T, Izuka J, Kobayashi H, Tanabe K. | | Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma. | | 51(4):646-653 |
| 113 | Ishiyama Y, Kondo T, Nemoto Y, Kobari Y, Ishihara H, Tachibana H, Yoshida K, Hashimoto Y, Takagi T, Iizuka J, Tanabe K | | Predictive Impact of Prognostic Nutritional Index on Pembrolizumab for Metastatic Urothelial Carcinoma Resistant to Platinum-based Chemotherapy. | | 41(3):1607-1614 |
| 114 | Nemoto Y, Kondo T, Ishihara H, Takagi T, Fukuda H, Yoshida K, Iizuka J, Ishida H, Tanabe K | | Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma. | | 26(3):552-561 |
| 115 | Takagi T, Yoshida K, Kondo T, Kobayashi H, Iizuka J, Okumi M, Ishida H, Tanabe K | | Comparisons of surgical outcomes between transperitoneal and retroperitoneal approaches in robot-assisted laparoscopic partial nephrectomy for lateral renal tumors: a propensity score-matched comparative analysis. | | 15(1):99-104. |
| 116 | Toguchi M, Takagi T, Ogawa Y, Morita S, Yoshida K, Kondo T, Iizuka J, Ishida H, Nagashima Y, Tanabe K | | Detection of a peritumoral pseudocapsule in patients with renal cell carcinoma undergoing robot-assisted partial nephrectomy using enhanced MDCT. | | 11(1):2245 |
| 117 | Ishihara H, Fukuda H, Takagi T, Kondo T, Tachibana H, Yoshida K, Iizuka J, Kobayashi H, Ishida H, Tanabe K | | Efficacy of nivolumab versus molecular-targeted therapy as second-line therapy for metastatic renal cell carcinoma: Real-world data from two Japanese institutions. | | 28(1):99-106 |
